Lutetium [177Lu] BL-ARC001 Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Breast CancerLung CancerSolid Tumors+1 more
Sichuan Baili Pharmaceutical Co., Ltd.22 enrolled1 locationNCT07274852
Recruiting
Phase 1
A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
Solid TumorsGastrointestinal Tumors
Sichuan Baili Pharmaceutical Co., Ltd.22 enrolled1 locationNCT07232407